Works matching IS 15228517 AND DT 2023 AND VI 25 AND IP 2


Results: 28
    1
    2

    Society News.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 431, doi. 10.1093/neuonc/noad010
    Publication type:
    Article
    3
    4
    6
    7
    9
    10
    11

    The NCI Glioblastoma Therapeutics Network (GTN).

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 221, doi. 10.1093/neuonc/noac247
    By:
    • Forry, Suzanne;
    • Hubbard, Leah;
    • Espey, Michael G;
    • Vikram, Bhadrasain;
    • Mann, Bhupinder;
    • Tawab-Amiri, Abdul;
    • Hecht, Toby
    Publication type:
    Article
    12
    13

    Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 224, doi. 10.1093/neuonc/noac221
    By:
    • Hoffman, Lindsey M;
    • Jaimes, Camilo;
    • Mankad, Kshitij;
    • Mirsky, David M;
    • Tamrazi, Benita;
    • Tinkle, Christopher L;
    • Kline, Cassie;
    • Ramasubramanian, Aparna;
    • Malbari, Fatema;
    • Mangum, Ross;
    • Lindsay, Holly;
    • Horne, Vincent;
    • Daniels, David J;
    • Keole, Sameer;
    • Grosshans, David R;
    • Poussaint, Tina Young;
    • Packer, Roger;
    • Cavalheiro, Sergio;
    • Bison, Brigitte;
    • Hankinson, Todd C
    Publication type:
    Article
    14
    15

    Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 351, doi. 10.1093/neuonc/noac185
    By:
    • Boele, Florien W;
    • Otter, Patricia W M den;
    • Reijneveld, Jaap C;
    • Hamer, Philip C de Witt;
    • Thuijl, Hinke F van;
    • Lorenz, Linda M C;
    • Wesseling, Pieter;
    • Lagerwaard, Frank J;
    • Taphoorn, Martin J B;
    • Kouwenhoven, Mathilde C M;
    • Snijders, Tom J;
    • Douw, Linda;
    • Klein, Martin
    Publication type:
    Article
    16
    17

    DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 315, doi. 10.1093/neuonc/noac177
    By:
    • Drexler, Richard;
    • Schüller, Ulrich;
    • Eckhardt, Alicia;
    • Filipski, Katharina;
    • Hartung, Tabea I;
    • Harter, Patrick N;
    • Divé, Iris;
    • Forster, Marie-Therese;
    • Czabanka, Marcus;
    • Jelgersma, Claudius;
    • Onken, Julia;
    • Vajkoczy, Peter;
    • Capper, David;
    • Siewert, Christin;
    • Sauvigny, Thomas;
    • Lamszus, Katrin;
    • Westphal, Manfred;
    • Dührsen, Lasse;
    • Ricklefs, Franz L
    Publication type:
    Article
    18
    19

    Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 339, doi. 10.1093/neuonc/noac173
    By:
    • Lassman, Andrew B;
    • Pugh, Stephanie L;
    • Wang, Tony J C;
    • Aldape, Kenneth;
    • Gan, Hui K;
    • Preusser, Matthias;
    • Vogelbaum, Michael A;
    • Sulman, Erik P;
    • Won, Minhee;
    • Zhang, Peixin;
    • Moazami, Golnaz;
    • Macsai, Marian S;
    • Gilbert, Mark R;
    • Bain, Earle E;
    • Blot, Vincent;
    • Ansell, Peter J;
    • Samanta, Suvajit;
    • Kundu, Madan G;
    • Armstrong, Terri S;
    • Wefel, Jeffrey S
    Publication type:
    Article
    20

    Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 303, doi. 10.1093/neuonc/noac171
    By:
    • Reyes-González, Jesús;
    • Barajas-Olmos, Francisco;
    • García-Ortiz, Humberto;
    • Magraner-Pardo, Lorena;
    • Pons, Tirso;
    • Moreno, Sergio;
    • Aguirre-Cruz, Lucinda;
    • Reyes-Abrahantes, Andy;
    • Martínez-Hernández, Angélica;
    • Contreras-Cubas, Cecilia;
    • Barrios-Payan, Jorge;
    • Ruiz-Garcia, Henry;
    • Hernandez-Pando, Rogelio;
    • Quiñones-Hinojosa, Alfredo;
    • Orozco, Lorena;
    • Abrahantes-Pérez, María del Carmen
    Publication type:
    Article
    21

    Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 290, doi. 10.1093/neuonc/noac169
    By:
    • Buehler, Marcel;
    • Yi, Xiao;
    • Ge, Weigang;
    • Blattmann, Peter;
    • Rushing, Elisabeth;
    • Reifenberger, Guido;
    • Felsberg, Joerg;
    • Yeh, Charles;
    • Corn, Jacob E;
    • Regli, Luca;
    • Zhang, Junyi;
    • Cloos, Ann;
    • Ravi, Vidhya M;
    • Wiestler, Benedikt;
    • Heiland, Dieter Henrik;
    • Aebersold, Ruedi;
    • Weller, Michael;
    • Guo, Tiannan;
    • Weiss, Tobias
    Publication type:
    Article
    22
    23

    Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 279, doi. 10.1093/neuonc/noac166
    By:
    • Voort, Sebastian R van der;
    • Incekara, Fatih;
    • Wijnenga, Maarten M J;
    • Kapsas, Georgios;
    • Gahrmann, Renske;
    • Schouten, Joost W;
    • Tewarie, Rishi Nandoe;
    • Lycklama, Geert J;
    • Hamer, Philip C De Witt;
    • Eijgelaar, Roelant S;
    • French, Pim J;
    • Dubbink, Hendrikus J;
    • Vincent, Arnaud J P E;
    • Niessen, Wiro J;
    • Bent, Martin J van den;
    • Smits, Marion;
    • Klein, Stefan
    Publication type:
    Article
    24

    Exposure to radon and heavy particulate pollution and incidence of brain tumors.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 407, doi. 10.1093/neuonc/noac163
    By:
    • Palmer, Joshua D;
    • Prasad, Rahul N;
    • Cioffi, Gino;
    • Kruchtko, Carol;
    • Zaorsky, Nicholas G;
    • Trifiletti, Daniel M;
    • Gondi, Vinai;
    • Brown, Paul D;
    • Perlow, Haley K;
    • Mishra, Mark V;
    • Chakravarti, Arnab;
    • Barnholtz-Sloan, Jill S;
    • Ostrom, Quinn T
    Publication type:
    Article
    25

    The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 326, doi. 10.1093/neuonc/noac155
    By:
    • Natsume, Atsushi;
    • Arakawa, Yoshiki;
    • Narita, Yoshitaka;
    • Sugiyama, Kazuhiko;
    • Hata, Nobuhiro;
    • Muragaki, Yoshihiro;
    • Shinojima, Naoki;
    • Kumabe, Toshihiro;
    • Saito, Ryuta;
    • Motomura, Kazuya;
    • Mineharu, Yohei;
    • Miyakita, Yasuji;
    • Yamasaki, Fumiyuki;
    • Matsushita, Yuko;
    • Ichimura, Koichi;
    • Ito, Kazumi;
    • Tachibana, Masaya;
    • Kakurai, Yasuyuki;
    • Okamoto, Naoko;
    • Asahi, Takashi
    Publication type:
    Article
    26

    Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 386, doi. 10.1093/neuonc/noac151
    By:
    • Upadhyaya, Santhosh A;
    • Campagne, Olivia;
    • Billups, Catherine A;
    • Orr, Brent A;
    • Onar-Thomas, Arzu;
    • Tatevossian, Ruth G;
    • Mostafavi, Roya;
    • Myers, Jason R;
    • Vinitsky, Anna;
    • Moreira, Daniel C;
    • Lindsay, Holly B;
    • Kilburn, Lindsay;
    • Baxter, Patricia;
    • Smith, Amy;
    • Crawford, John R;
    • Partap, Sonia;
    • Bendel, Anne E;
    • Aguilera, Dolly G;
    • Nichols, Kim E;
    • Rampersaud, Evadnie
    Publication type:
    Article
    27

    Dysfunctional dendritic cells limit antigen-specific T cell response in glioma.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 263, doi. 10.1093/neuonc/noac138
    By:
    • Friedrich, Mirco;
    • Hahn, Markus;
    • Michel, Julius;
    • Sankowski, Roman;
    • Kilian, Michael;
    • Kehl, Niklas;
    • Günter, Manina;
    • Bunse, Theresa;
    • Pusch, Stefan;
    • Deimling, Andreas von;
    • Wick, Wolfgang;
    • Autenrieth, Stella E;
    • Prinz, Marco;
    • Platten, Michael;
    • Bunse, Lukas
    Publication type:
    Article
    28

    Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 2, p. 248, doi. 10.1093/neuonc/noac135
    By:
    • Lim, Yi Chieh;
    • Jensen, Kamilla E;
    • Aguilar-Morante, Diana;
    • Vardouli, Lina;
    • Vitting-Seerup, Kristoffer;
    • Gimple, Ryan C;
    • Wu, Qiulian;
    • Pedersen, Henriette;
    • Elbaek, Kirstine J;
    • Gromova, Irina;
    • Ihnatko, Robert;
    • Kristensen, Bjarne W;
    • Petersen, Jeanette K;
    • Skjoth-Rasmussen, Jane;
    • Flavahan, William;
    • Rich, Jeremy N;
    • Hamerlik, Petra
    Publication type:
    Article